Key Executives

  • John Rim
    John Rim
    President & CEO
    John Rim is President & CEO at Samsung Biologics.
    Prior to joining Samsung Biologics in 2018, Mr. Rim worked for Genentech/Roche in a variety of senior global leadership roles in Technical Operations, Product Development, and Research and Development in the US and Europe.

    Mr. Rim has also held senior leadership roles with Astellas Pharmaceuticals in General Management, Sales & Marketing, Technical Operations, Customer Service, Business Development, and Strategic Planning.

    Mr. Rim has over 30 years’ experience in the biopharmaceutical industry and began his career as a management consultant with Booz, Allen & Hamilton consulting to pharmaceutical companies in the US and Europe.

    Mr. Rim holds a bachelor’s degree from Columbia University, a master’s degree from Stanford University, and an MBA from the Kellogg School of Management at Northwestern University.
  • Kevin Sharp
    Kevin Sharp
    Executive Vice President
    Kevin Sharp is Executive Vice President and Head of Sales & Operations Department.
    Mr. Sharp holds over 24 years of experience in the biopharmaceutical and pharmaceutical industry.

    Prior to joining Samsung Biologics in 2017, Mr. Sharp worked in areas of sales, business development and procurement at global pharmaceutical companies such as GSK and Contract Pharmaceutical Corp.
    Mr. Sharp holds an MBA from Temple University, Philadelphia, PA.
  • James Choi
    James Choi
    Executive Vice President
    James Choi is Executive Vice President, Chief Marketing Officer and Head of Sales Support, Project Management, and Global Public Affairs.
    Mr. Choi has over 35 years of senior leadership experience in the healthcare and informatics industries in various roles including customer service, operations, information technology, and security.

    Prior to joining Samsung Biologics in 2014, Mr. Choi was CIO at Beckman Coulter's Clinical Diagnostics and Life Sciences businesses, CIO and CTO at Altegrity, and Senior Director of Information Systems, Customer Services eBusiness Technology, and Site Planning at Philips Healthcare.

    Mr. Choi holds a bachelor's degree in Mechanical Engineering from the University of California Irvine and an MBA from the University of Southern California.
  • Pierre Catignol
    Pierre Catignol
    Executive Vice President
    Pierre Catignol is Executive Vice President and Head of Operation Center.
    Mr. Catignol has over 25 years of experience in the biopharmaceutical and pharmaceutical industry.

    Prior to joining Samsung Biologics, Mr. Catignol began his career at Sanofi-Pasteur in 1995, and extended his career in StALLERGENES AND VIRBAC as Head of Operations & Supply site and Operations & Quality respectively.

    His recent leadership role was at Lonza as Head of Portsmouth site.

    Mr. Catignol holds a master's degree for General Engineering at ECAM university.
  • Kun Lo, Ph.D.
    Kun Lo, Ph.D.
    Executive Vice President
    Kun Lo is Executive Vice President, Head of EPCV Center responsible for construction and operation of new plants, and CSO (Chief Safety Officer).
    Prior to joining Samsung Biologics in 2020, Dr. Lo held various management positions in Engineering and New Business.

    Dr. Lo began his career with Samsung General Chemicals in 1992, then developed chemical products and managed manufacturing for 18 years in Samsung Total Petrochemical. In 2013, Dr. Lo advanced through Engineering expertise as a manager of Engineering Support Team and Process Design in Samsung Engineering.

    Dr. Lo assumed responsibilities for planning global business as a New Business Team Leader and Head of US corporation in Samsung Engineering.

    Dr. Lo holds a doctor’s degree from Seoul National University in Chemical Engineering.
  • Hosung Min, Ph.D.
    Hosung Min, Ph.D.
    Executive Vice President
    Hosung Min is Executive Vice President and Head of CDO Development Center. Dr. Min serves concurrently as Head of Bio R&D Center.
    Dr. Min has background in antibody drug development at Amgen, a global pharmaceutical company. His experience also includes leadership role of process development and Drug Substance (DS) manufacturing of biosimilar products at Samsung Bioepis.

    Dr. Min received his Ph.D. in Molecular Biology from UCLA and BA in Molecular Biology from UC Berkeley.
  • Seungho Ryu
    Seungho Ryu
    Executive Vice President & CFO
    Seungho Ryu is Executive Vice President and Head of Business Management Department.
    Seung Ho Ryu is an Executive Vice President and Head of the Business Support Center.
    Prior to joining Samsung Biologics, Mr. Ryu started his career at Samsung Electronics and has been carrying out business management for more than 25 years including his career at SEF(Samsung Electronics France) and Samsung Headquarters.
  • Kyuho Lee
    Kyuho Lee
    Executive Vice President & CHRO
    Kyuho Lee is Executive Vice President, Head of People Center, and CHRO (Chief Human Resource Officer).
    Mr. Lee has carried out HR management tasks for 31 years.

    Prior to joining Samsung Biologics, Mr. Lee managed HR support tasks, global HR tasks, and labor-management tasks at Samsung Electronics, including working as the HR team leader of the VD business division.
  • Dongjoong Kim
    Dongjoong Kim
    Executive Vice President
    Dongjoong Kim is Executive Vice President and Head of Co-Prosperity Cooperation Center.
    Prior to joining Samsung Biologics in 2014, Mr. Kim held various corporate planning and managerial leadership positions for Samsung Electronics.

    Mr. Kim began his career with Samsung in 1988. Mr. Kim led the Corporate Management and Administration of Samsung Electronics from 2002 to 2014.
  • Heejeong Kim
    Heejeong Kim
    Vice President
    Heejeong Kim is Vice President and Head of Drug Substance Department.
    Ms. Kim joined Samsung Biologics in 2011, and after serving as a plant team leader & Operation Support team leader for Drug Substance MFG, she now overlooks the entire Drug Substance area.

    Ms. Kim received her master's degree for Food Science and Biotechnology from Seoul National University in 2006.
  • Sangwon Seo
    Sangwon Seo
    Vice President
    Sangwon Seo is Vice President and Head of Sales&Operation Department.
    Prior to joining Samsung Biologics in 2011, Mr. Seo was at Samsung Electronics.

    Mr. Seo acquired a M.S. in Bioengineering from POSTECH.
  • Yong Park
    Yong Park
    Vice President
    Yong Park is Vice President, Head of Quality Strategy Department.
    Mr. Park has over 25 years of experience in managing human resources.

    Prior to joining Samsung Biologics, Mr. Park began his career at Samsung Electronics as HR manager for the headquarters, and expanded his experience at Samsung Electronics by overseeing HR team for Western Asia and North America.

    Mr. Park holds an MBA from Purdue University.
  • Taeheui Lee
    Taeheui Lee
    Vice President
    Taeheui Lee is Vice President and Head of Antibody Cell Culture Process Development Team.
    Mr. Lee is experienced in R&D functions such as biologics process development, project management, analysis, etc. at Samsung Advanced Institute of Technology, Samsung Bioepis and Samsung Biologics, where he joined in 2024.

    Mr. Lee received an M.S. in Structural Biology from POSTECH.
  • Sangmyung Lee
    Sangmyung Lee
    Vice President
    Sangmyung Lee is Vice President and Head of Business Strategy.
    After joining Samsung Life Insurance in 2003, Mr. Lee handled various management support roles including the areas of finance, project management, mid-to-long term strategy T/F, etc. at Samsung Bioepis and Samsung Electronics.

    Mr. Lee joined Samsung Biologics in 2023 and is now contributing to the design and execution of the company's business strategy.
  • Jaesun Lee
    Jaesun Lee
    Vice President
    Jaesun Lee is Vice President and Head of Operational Excellence Department.
    Mr. Lee started his career at Samsung Electronics' semiconductor division in 1989. He then led system setup and automation of new production lines at Samsung Electronics and Samsung Display.

    Mr. Lee joined Samsung Biologics in 2023 and is now contributing to Digital Transformation based on his expertise - in MES.
  • Yeowan Youn
    Yeowan Youn
    Vice President
    Yeowan Youn is Vice President and Head of Legal Compliance Team.
    Prior to joining Samsung Biologics in 2024, Mr. Youn was at Samsung Fire & Marine Insurance, Samsung Electronics, and Samsung Electronics America.

    Mr. Youn obtained his Juris Doctor degree from Syracuse University.
  • Youngsuk Song
    Youngsuk Song
    Vice President
    Youngsuk Song is Vice President and Head of HR Support Department.
    Mr. Song has experience in diverse HR roles including recruitment, HR operation, HR policy, and labor relations management. Mr. Song also worked at Samsung Techwin (current Hanwha Aerospace) and Samsung Electronics.

    Mr. Song joined Samsung Biologics in 2015 and is now contributing to achieving business goals by building stable labor-management relations and managing workforce in an efficient manner.
  • Insub Song
    Insub Song
    Vice President
    Insub Song is Vice President and Head of Procurement Team.
    Prior to joining Samsung Biologics in 2011, Mr. Song worked at Samsung Techwin and Samsung Electronics.

    Mr. Song managed SCM functions including procurement, materials, and logistics.

    Mr. Song holds an MBA from Aalto University.
  • Heekyun Lim
    Heekyun Lim
    Vice President
    Heekyun Lim is Vice President and Head of Business Consulting Team.
    Mr. Lim has over 20 years of experience with extensive expertise in strategic management and bio research for Samsung Electronics.

    Mr. Lim holds a master’s degree for life sciences from Pohang University of Science and Technology.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION